Literature DB >> 12456657

Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAs.

Simon Rousseau1, Nick Morrice, Mark Peggie, David G Campbell, Matthias Gaestel, Philip Cohen.   

Abstract

Lipopolysaccharide (LPS) stimulates production of inflammatory mediators, partly by stabilizing [interleukin-6 (IL-6), cyclooxygenase 2 (COX-2)] and/or stimulating translation [tumour necrosis factor-alpha (TNF-alpha)] of their mRNAs. Such regulation depends on AU-rich elements (AREs) within the 3'-untranslated regions and is partially suppressed by SB 203580 (which inhibits SAPK2a/p38). The LPS-induced production of TNF-alpha and IL-6 is suppressed in MAPKAP-K2-deficient mice (a kinase activated by SAPK2a/p38). Here, we identify 18 macrophage proteins that bind to AREs and show that hnRNP A0 is a major substrate for MAPKAP-K2 in this fraction. MAPKAP-K2 phosphorylated hnRNP A0 at Ser84 in vitro and this residue became phosphorylated in LPS-stimulated cells. Phosphorylation was prevented by SB 203580 and suppressed in macrophages derived from MAPKAP-K2-deficient mice. The mRNAs encoding TNF-alpha, COX-2 and macrophage inflammatory protein-2 (MIP-2) bound to hnRNP A0 in LPS-stimulated macrophages, an interaction prevented by SB 203580. The LPS-induced stabilization of MIP-2 mRNA and production of MIP-2 protein were abolished when macrophages were incubated with SB 203580 plus PD 184352 (which inhibits the classical MAP kinase cascade). Our data suggest that LPS-induced binding of hnRNP A0 to AREs may contribute to the post-transcriptional regulation of specific mRNAs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12456657      PMCID: PMC136943          DOI: 10.1093/emboj/cdf639

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  32 in total

1.  Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA.

Authors:  C Gueydan; L Droogmans; P Chalon; G Huez; D Caput; V Kruys
Journal:  J Biol Chem       Date:  1999-01-22       Impact factor: 5.157

2.  Identification of mitogen-activated protein (MAP) kinase-activated protein kinase-3, a novel substrate of CSBP p38 MAP kinase.

Authors:  M M McLaughlin; S Kumar; P C McDonnell; S Van Horn; J C Lee; G P Livi; P R Young
Journal:  J Biol Chem       Date:  1996-04-05       Impact factor: 5.157

3.  A protein kinase involved in the regulation of inflammatory cytokine biosynthesis.

Authors:  J C Lee; J T Laydon; P C McDonnell; T F Gallagher; S Kumar; D Green; D McNulty; M J Blumenthal; J R Heys; S W Landvatter; J E Strickler; M M McLaughlin; I R Siemens; S M Fisher; G P Livi; J R White; J L Adams; P R Young
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

4.  PRAK, a novel protein kinase regulated by the p38 MAP kinase.

Authors:  L New; Y Jiang; M Zhao; K Liu; W Zhu; L J Flood; Y Kato; G C Parry; J Han
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

5.  A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA.

Authors:  S H Ridley; J L Dean; S J Sarsfield; M Brook; A R Clark; J Saklatvala
Journal:  FEBS Lett       Date:  1998-11-13       Impact factor: 4.124

6.  Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB.

Authors:  M Deak; A D Clifton; L M Lucocq; D R Alessi
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

7.  Distinct cellular functions of MK2.

Authors:  Alexey Kotlyarov; Yvonne Yannoni; Susann Fritz; Kathrin Laass; Jean-Baptiste Telliez; Deborah Pitman; Lih-Ling Lin; Matthias Gaestel
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

8.  The substrate specificity and structure of mitogen-activated protein (MAP) kinase-activated protein kinase-2.

Authors:  D Stokoe; B Caudwell; P T Cohen; P Cohen
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

9.  Isolation and characterization of a novel, low abundance hnRNP protein: A0.

Authors:  V E Myer; J A Steitz
Journal:  RNA       Date:  1995-04       Impact factor: 4.942

10.  MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase.

Authors:  D Stokoe; D G Campbell; S Nakielny; H Hidaka; S J Leevers; C Marshall; P Cohen
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  66 in total

Review 1.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

2.  p38gamma regulates interaction of nuclear PSF and RNA with the tumour-suppressor hDlg in response to osmotic shock.

Authors:  Guadalupe Sabio; María I Cerezo-Guisado; Paloma Del Reino; Francisco A Iñesta-Vaquera; Simon Rousseau; J Simon C Arthur; David G Campbell; Francisco Centeno; Ana Cuenda
Journal:  J Cell Sci       Date:  2010-07-06       Impact factor: 5.285

Review 3.  Is post-transcriptional stabilization, splicing and translation of selective mRNAs a key to the DNA damage response?

Authors:  H Christian Reinhardt; Ian G Cannell; Sandra Morandell; Michael B Yaffe
Journal:  Cell Cycle       Date:  2011-01-01       Impact factor: 4.534

4.  A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy.

Authors:  Karl A Merrick; Sandra Morandell; Chang-Qi Zhu; Ian G Cannell; Christian J Braun; Robert A Grant; Eleanor R Cameron; Ming-Sound Tsao; Michael T Hemann; Michael B Yaffe
Journal:  Cancer Cell       Date:  2015-11-09       Impact factor: 31.743

5.  Peptide inhibitors of MK2 show promise for inhibition of abdominal adhesions.

Authors:  Brian C Ward; Sandra Kavalukas; Jamie Brugnano; Adrian Barbul; Alyssa Panitch
Journal:  J Surg Res       Date:  2011-02-23       Impact factor: 2.192

6.  MAPK regulation of maternal and zygotic Notch transcript stability in early development.

Authors:  Foster C Gonsalves; David A Weisblat
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-03       Impact factor: 11.205

Review 7.  Adipokines and the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Peptides       Date:  2007-05-06       Impact factor: 3.750

Review 8.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Curr Opin Cell Biol       Date:  2009-02-21       Impact factor: 8.382

9.  Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinase-activated protein kinase 2.

Authors:  Hoanh Tran; Fabienne Maurer; Yoshikuni Nagamine
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  Structural and functional dissection of a conserved destabilizing element of cyclo-oxygenase-2 mRNA: evidence against the involvement of AUF-1 [AU-rich element/poly(U)-binding/degradation factor-1], AUF-2, tristetraprolin, HuR (Hu antigen R) or FBP1 (far-upstream-sequence-element-binding protein 1).

Authors:  Gareth Sully; Jonathan L E Dean; Robin Wait; Lesley Rawlinson; Tomas Santalucia; Jeremy Saklatvala; Andrew R Clark
Journal:  Biochem J       Date:  2004-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.